Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study
/in Colorectal Cancer, Hyperthermia, International PublicationsA phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
/in Colorectal Cancer, Dendritic Cells, International PublicationsPI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsIn Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
/in Colorectal Cancer, Hyperthermia, International PublicationsDendritic cell-based cancer immunotherapy for colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsProspective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International PublicationsLong-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International PublicationsDendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsValidity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
/in Colorectal Cancer, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer